Daewon Pharmaceutical Co., Ltd. (KRX:003220)
10,810
-60 (-0.55%)
Apr 29, 2026, 3:30 PM KST
Daewon Pharmaceutical Market Cap
Daewon Pharmaceutical has a market cap or net worth of 232.98 billion as of April 28, 2026. Its market cap has decreased by -18.70% in one year.
Market Cap
232.98B
Enterprise Value
367.20B
Revenue
605.43B
Ranking
n/a
PE Ratio
n/a
Stock Price
10,810.00
Market Cap Chart
Since March 1, 2001, Daewon Pharmaceutical's market cap has increased from 18.06B to 232.98B, an increase of 1,190.05%. That is a compound annual growth rate of 10.69%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samjin Pharmaceuticals | 232.04B |
| Hyundai Pharmaceutical | 239.14B |
| Chong Kun Dang Holdings | 240.41B |
| Boditech Med | 241.49B |
| HLB Pharmaceutical | 242.93B |
| Suheung | 218.94B |
| AptaBio Therapeutics | 217.72B |
| Ilyang Pharmaceutical Co.,Ltd | 212.23B |